255 related articles for article (PubMed ID: 17363620)
1. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
[TBL] [Abstract][Full Text] [Related]
2. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
3. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
[TBL] [Abstract][Full Text] [Related]
4. Dysferlin and the plasma membrane repair in muscular dystrophy.
Bansal D; Campbell KP
Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
[TBL] [Abstract][Full Text] [Related]
5. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.
Huang Y; Laval SH; van Remoortere A; Baudier J; Benaud C; Anderson LV; Straub V; Deelder A; Frants RR; den Dunnen JT; Bushby K; van der Maarel SM
FASEB J; 2007 Mar; 21(3):732-42. PubMed ID: 17185750
[TBL] [Abstract][Full Text] [Related]
6. Developmental and tissue-specific regulation of a novel dysferlin isoform.
Salani S; Lucchiari S; Fortunato F; Crimi M; Corti S; Locatelli F; Bossolasco P; Bresolin N; Comi GP
Muscle Nerve; 2004 Sep; 30(3):366-74. PubMed ID: 15318348
[TBL] [Abstract][Full Text] [Related]
7. Intracellular localization of dysferlin and its association with the dihydropyridine receptor.
Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S
Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931
[TBL] [Abstract][Full Text] [Related]
8. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
9. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
Piccolo F; Moore SA; Ford GC; Campbell KP
Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
[TBL] [Abstract][Full Text] [Related]
11. Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.
Hofhuis J; Bersch K; Büssenschütt R; Drzymalski M; Liebetanz D; Nikolaev VO; Wagner S; Maier LS; Gärtner J; Klinge L; Thoms S
J Cell Sci; 2017 Mar; 130(5):841-852. PubMed ID: 28104817
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro dysferlin expression in human muscle satellite cells.
De Luna N; Gallardo E; Illa I
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1104-13. PubMed ID: 15535137
[TBL] [Abstract][Full Text] [Related]
13. Dysferlin expression in tubular aggregates: their possible relationship to endoplasmic reticulum stress.
Ikezoe K; Furuya H; Ohyagi Y; Osoegawa M; Nishino I; Nonaka I; Kira J
Acta Neuropathol; 2003 Jun; 105(6):603-9. PubMed ID: 12664320
[TBL] [Abstract][Full Text] [Related]
14. Increased dysferlin expression in Duchenne muscular dystrophy.
Vontzalidis A; Terzis G; Manta P
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
[TBL] [Abstract][Full Text] [Related]
15. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
[TBL] [Abstract][Full Text] [Related]
16. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
[TBL] [Abstract][Full Text] [Related]
17. The C2 domains of dysferlin: roles in membrane localization, Ca
Muriel J; Lukyanenko V; Kwiatkowski T; Bhattacharya S; Garman D; Weisleder N; Bloch RJ
J Physiol; 2022 Apr; 600(8):1953-1968. PubMed ID: 35156706
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the dysferlin skeletal muscle promoter.
Foxton RM; Laval SH; Bushby KM
Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310
[TBL] [Abstract][Full Text] [Related]
19. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
20. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN
Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]